Raiffeisen Bank International AG Purchases 120,000 Shares of Option Care Health, Inc. $OPCH

Raiffeisen Bank International AG grew its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 92.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 250,000 shares of the company’s stock after purchasing an additional 120,000 shares during the quarter. Raiffeisen Bank International AG owned approximately 0.17% of Option Care Health worth $5,330,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. McIlrath & Eck LLC bought a new stake in shares of Option Care Health during the second quarter worth approximately $37,000. Advisory Services Network LLC bought a new position in Option Care Health in the third quarter valued at approximately $35,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Option Care Health during the 3rd quarter valued at $38,000. Employees Retirement System of Texas bought a new stake in shares of Option Care Health during the 4th quarter valued at $45,000. Finally, EverSource Wealth Advisors LLC lifted its stake in shares of Option Care Health by 528.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after purchasing an additional 1,183 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Performance

OPCH stock opened at $24.21 on Friday. The business’s 50-day moving average price is $22.80 and its two-hundred day moving average price is $24.86. The company has a current ratio of 1.47, a quick ratio of 0.98 and a debt-to-equity ratio of 0.91. The firm has a market cap of $3.63 billion, a PE ratio of 18.20, a P/E/G ratio of 1.42 and a beta of 0.61. Option Care Health, Inc. has a 1-year low of $18.01 and a 1-year high of $36.80.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The firm had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.42 billion. During the same period in the previous year, the firm earned $0.41 earnings per share. The company’s revenue was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. As a group, research analysts forecast that Option Care Health, Inc. will post 1.69 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have recently issued reports on OPCH shares. The Goldman Sachs Group began coverage on Option Care Health in a research report on Monday, June 8th. They issued a “neutral” rating and a $22.00 price target on the stock. Weiss Ratings lowered Option Care Health from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, August 27th. Zacks Research upgraded Option Care Health from a “strong sell” rating to a “hold” rating in a report on Monday, July 6th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $24.00 target price (down from $26.00) on shares of Option Care Health in a research report on Thursday, July 30th. Finally, Wall Street Zen upgraded shares of Option Care Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $29.92.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.